Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Inmune Bio, Inc. Director's Dealing 2019

Aug 16, 2019

34518_dirs_2019-08-16_5c5a8512-010c-403e-8de1-566c86818e8b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-08-06

Reporting Person: Baracchini Edgardo Jr (Director)

More from Inmune Bio, Inc.

Regulatory Filings 2026
Jun 2
Proxy Solicitation & Information Statement 2026
Apr 23
Regulatory Filings 2026
Feb 27
Regulatory Filings 2026
Feb 23
Regulatory Filings 2026
Feb 19
Regulatory Filings 2026
Feb 13
Regulatory Filings 2026
Jan 27
Capital/Financing Update 2025
Dec 23
Capital/Financing Update 2025
Dec 19
Capital/Financing Update 2025
Dec 19
View all filings →